Sign In
Buy SNANF
$0.211
+0.0055 (+2.68%)
At Close: Jun 02, 2026
Sona Nanotech confirms THT's potential to enhance immunotherapy efficacy in preclinical study
10:13am, Wednesday, 19'th Mar 2025
Sona Nanotech Inc (CSE:SONA, OTCQB:SNANF) announced that a follow-up preclinical study has confirmed the efficacy of its Targeted Hyperthermia Therapy (THT) in immunotherapy-resistant cancer. The comp
Halifax, Nova Scotia--(Newsfile Corp. - March 19, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to provide updated data confirming efficacy of its Targeted H
Sona Nanotech Inc. CEO David Regan to Present at the Investor Summit Virtual on March 11
07:30am, Thursday, 06'th Mar 2025
NEW YORK, NY / ACCESS Newswire / March 6, 2025 / David Regan, CEO of Sona Nanotech Inc. (OTCQB:SNANF)(CSE:SONA), will be presenting at this year's Investor Summit Virtual on March 11th at 11:30am ET.
Sona Nanotech's Targeted Hyperthermia Therapy To Be Presented at the International 19th Canadian Melanoma Conference
08:23am, Wednesday, 12'th Feb 2025
Halifax, Nova Scotia--(Newsfile Corp. - February 12, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that its recently published findings from its
Sona Nanotech's gold nanorod study hits peer-reviewed journal - ICYMI
11:03am, Saturday, 01'st Feb 2025
Sona Nanotech Inc (CSE:SONA, OTCQB:SNANF) earlier this week announced the publication of its preclinical cancer therapy study in Frontiers in Immunology. The company explained that its patented gold n
Sona Nanotech's bold bet on cancer therapy: gold nanorods and the fight against “cold tumors”
10:31am, Friday, 31'st Jan 2025
For decades, cancer researchers have grappled with a stubborn challenge: the body's immune system often fails to recognize and attack tumors. While immunotherapies like Merck's Keytruda have revolutio
Sona Nanotech: Peer-reviewed article underlines the potential of unique cancer therapy
10:02am, Wednesday, 22'nd Jan 2025
Sona Nanotech Inc (CSE:SONA, OTCQB:SNANF) has taken a significant step forward with its experimental cancer treatment, Targeted Hyperthermia Therapy (THT). The results of its preclinical studies on br
Sona Nanotech's THT Cancer Therapy Preclinical Efficacy Studies Published In Peer-Reviewed Scientific Journal
09:22am, Monday, 13'th Jan 2025
Halifax, Nova Scotia--(Newsfile Corp. - January 13, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that the now complete findings from our previou
Halifax, Nova Scotia--(Newsfile Corp. - December 11, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") announces results from its most recent preclinical study of its Targe
Sona Nanotech to Showcase Its THT Cancer Therapy at NCL 20th Anniversary Symposium and Provides Corporate Update
08:15am, Thursday, 07'th Nov 2024
Halifax, Nova Scotia--(Newsfile Corp. - November 7, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that its Chief Scientific Officer, Dr. Len Pagl
Sona Nanotech Issued Patent and Appoints New Board Member
04:32pm, Monday, 21'st Oct 2024
Halifax, Nova Scotia--(Newsfile Corp. - October 21, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce the issuance of U.S. Patent No. 12117447 by the
Sona Nanotech Grants Options
08:11am, Wednesday, 09'th Oct 2024
Halifax, Nova Scotia--(Newsfile Corp. - October 9, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has granted 25,000 incentive stock opt
Sona Nanotech Closes Private Placement Financing to Raise $1,643,750 in Gross Proceeds
08:47am, Tuesday, 24'th Sep 2024
Halifax, Nova Scotia--(Newsfile Corp. - September 24, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has closed its non-brokered private
Sona Nanotech Closes Private Placement Financing to Raise $1,500,000 in Gross Proceeds and Announces Additional Financing
08:25am, Thursday, 05'th Sep 2024
Halifax, Nova Scotia--(Newsfile Corp. - September 5, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has closed its non-brokered private
Sona Nanotech to Arrange Private Placement Financing
08:22am, Wednesday, 31'st Jul 2024
Halifax, Nova Scotia--(Newsfile Corp. - July 31, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that it plans to raise up to $1,500,000 through a
